Showing results (81-90 of 86) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
The Lancet. Oncology|December 15, 2015
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 studyAsher Chanan-Khan, Paula Cramer, Fatih Demirkan, et al.Bone Marrow Transplantation|April 21, 2001
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)H M Lazarus, F R Loberiza, M J Zhang, et al.Bioorganic & Medicinal Chemistry|February 5, 2000
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitorJ V Prasad, F E Boyer, J M Domagala, et al.Lancet (London, England)|December 10, 2025
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trialLorenzo Falchi, Marcel Nijland, Huiqiang Huang, et al.Bone Marrow Transplantation|December 4, 2003
Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of ageD E Reece, C Bredeson, W S Pérez, et al.Cancer Investigation|August 20, 2015
BCR-ABL mutations in chronic myeloid leukemia treated with tyrosine kinase inhibitors and impact on survivalKatia Borgia Barbosa Pagnano, Israel Bendit, Carla Boquimpani, et al.Pageof 9